Brief: Rallybio Announces Publication Of Rlyb212 Phase 1 Proof-Of-Concept Study Results
29/08/2024 13:03
Aug 29 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO ANNOUNCES PUBLICATION OF RLYB212 PHASE 1
PROOF-OF-CONCEPT STUDY RESULTS IN THROMBOSIS AND HAEMOSTASIS
* RALLYBIO CORP - ON TRACK TO INITIATE RLYB212 PHASE 2 DOSE
CONFIRMATION TRIAL IN PREGNANT WOMEN AT HIGHER RISK FOR FNAIT IN
4Q 2024
Source text for Eikon: ID:nBw1C8RBba
Further company coverage: RLYB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx